Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Rang in Aktien #115
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Aktienkurs
$100.21
Zuletzt synchronisiert: 2026-10-05
Marktkapitalisierung
$173.40B
Veränderung (1 Tag)
2.83%
Veränderung (1 Jahr)
-25.07%
Land
US
Handel Abbott Laboratories (ABT)

Kategorie

Preis ABT mit Marktkapitalisierung von B
Abbott Laboratories Abbott Laboratories
ABT
$100.21
Marktkapitalisierung von Abbott Laboratories(ABT)
Marktkapitalisierung: $173.40B
Mit Stand October 2026 hat Abbott Laboratories eine Marktkapitalisierung von $173.40B. Das macht Abbott Laboratories laut unseren Daten zum 115th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Abbott Laboratories von 1968 bis 2026
ABT im Vergleich zu den Top 5 der beliebtesten stocks
Preis für ABT Vermögenswert B Marktkapitalisierung von B Ergebnisse
Abbott Laboratories Abbott Laboratories
$3,356.03 $173.40B
$5.807T +3,249.00%
Abbott Laboratories Abbott Laboratories
$2,826.39 $173.40B
$4.891T +2,720.47%
Abbott Laboratories Abbott Laboratories
$2,414.09 $173.40B
$4.177T +2,309.03%
Abbott Laboratories Abbott Laboratories
$2,264.53 $173.40B
$3.919T +2,159.79%
Abbott Laboratories Abbott Laboratories
$1,574.23 $173.40B
$2.724T +1,470.93%